Literature DB >> 9188589

Identification and analysis of three myristylated vaccinia virus late proteins.

K H Martin1, D W Grosenbach, C A Franke, D E Hruby.   

Abstract

Previous studies have shown that at least three vaccinia virus (VV) late proteins (with apparent molecular asses of 37, 35, and 25 kDa) label with myristic acid. Time course labeling of VV-infected cells with [3H]myristic acid reveals at least three additional putative myristylproteins, with apparent molecular masses of 92, 17, and 14 kDa. The 25-kDa protein has previously been identified as that encoded by the L1R open reading frame, leaving the identities of the remaining proteins to be determined. Sequence analysis led to the preliminary identification of the 37-, 35-, and 17-kDa proteins as G9R, A16L, and E7R, respectively. Using synthetic oligonucleotides and PCR techniques, each of these open reading frames was amplified by using VV DNA as a template and then cloned individually into expression vectors behind T7 promoters. These plasmid constructs were then transcribed in vitro, and the resulting mRNAs were translated in wheat germ extracts and radiolabeled with either [35S]methionine or [3H]myristic acid. Each wild-type polypeptide was labeled with [35S]methionine or [3H]myristic acid in the translation reactions, while mutants containing an alanine in place of glycine at the N terminus were labeled only with [35S]methionine, not with myristic acid. This result provided strong evidence that the open reading frames had been correctly identified and that each protein is myristylated on a glycine residue adjacent to the initiating methionine. Subcellular fractionations of VV-infected cells suggested that A16L and E7R are soluble, in contrast to L1R, which is a membrane-associated protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188589      PMCID: PMC191757          DOI: 10.1128/JVI.71.7.5218-5226.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  The complete DNA sequence of vaccinia virus.

Authors:  S J Goebel; G P Johnson; M E Perkus; S W Davis; J P Winslow; E Paoletti
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

2.  Myristoylation of an inhibitory GTP-binding protein alpha subunit is essential for its membrane attachment.

Authors:  T L Jones; W F Simonds; J J Merendino; M R Brann; A M Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Myristylation and polylysine-mediated activation of the protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).

Authors:  T D Chung; J P Wymer; M Kulka; C C Smith; L Aurelian
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

4.  Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.

Authors:  D Marc; G Masson; M Girard; S van der Werf
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Myristylated polyomavirus VP2: role in the life cycle of the virus.

Authors:  N Krauzewicz; C H Streuli; N Stuart-Smith; M D Jones; S Wallace; B E Griffin
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.

Authors:  D Gheysen; E Jacobs; F de Foresta; C Thiriart; M Francotte; D Thines; M De Wilde
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

7.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

8.  Myristoylation-dependent replication and assembly of human immunodeficiency virus 1.

Authors:  M Bryant; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

9.  Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.

Authors:  H G Kräusslich; C Hölscher; Q Reuer; J Harber; E Wimmer
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

10.  Site-directed mutations in the Sindbis virus 6K protein reveal sites for fatty acylation and the underacylated protein affects virus release and virion structure.

Authors:  K Gaedigk-Nitschko; M X Ding; M A Levy; M J Schlesinger
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

View more
  20 in total

1.  Genome-wide analysis of vaccinia virus protein-protein interactions.

Authors:  S McCraith; T Holtzman; B Moss; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex.

Authors:  Suany Ojeda; Arban Domi; Bernard Moss
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Poxvirus multiprotein entry-fusion complex.

Authors:  Tatiana G Senkevich; Suany Ojeda; Alan Townsley; Gretchen E Nelson; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-08       Impact factor: 11.205

4.  Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene.

Authors:  Suany Ojeda; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies.

Authors:  Hua-Poo Su; Scott C Garman; Timothy J Allison; Christiana Fogg; Bernard Moss; David N Garboczi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-10       Impact factor: 11.205

Review 6.  N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections.

Authors:  Tatsiana Kosciuk; Hening Lin
Journal:  ACS Chem Biol       Date:  2020-06-10       Impact factor: 5.100

7.  Protein Primary Structure of the Vaccinia Virion at Increased Resolution

Authors:  Tuan Ngo; Yeva Mirzakhanyan; Nissin Moussatche; Paul David Gershon
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

8.  Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.

Authors:  Markus Cornberg; Brian S Sheridan; Frances M Saccoccio; Michael A Brehm; Liisa K Selin
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  The genome of Melanoplus sanguinipes entomopoxvirus.

Authors:  C L Afonso; E R Tulman; Z Lu; E Oma; G F Kutish; D L Rock
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 10.  Monkeypox virus and insights into its immunomodulatory proteins.

Authors:  Jessica R Weaver; Stuart N Isaacs
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.